Novo Nordisk: Obesity war heating up, but Danish giant can still be a winner

• click to rate

  Posted by Two Blokes Jul 8 - Filed in Stock - 5 views
  
  Novo Nordisk (NYSE:NVO) is losing ground in Europe's red-hot market for weight-loss and diabetes drugs. Its rival, Eli Lilly and Co (NYSE:LLY) is racing ahead, and investors are taking notice.